商业-话题@MedSci

#商业#

128篇内容 | 2931人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1771734, encodeId=b34f1e717349f, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=两票制下，制药企业和商业企业怎么合作？, objectType=article, longId=97956, objectId=d92c9e95686, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d92c9e95686, replyNumber=0, likeNumber=58, createdTime=2017-12-02, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d92c9e95686, moduleTitle=两票制下，制药企业和商业企业怎么合作？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d92c9e95686)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771720, encodeId=d3711e717205b, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=移动医疗医生端构建商业模式中的几个大坑（中）, objectType=article, longId=89936, objectId=cdd48993669, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdd48993669, replyNumber=0, likeNumber=69, createdTime=2018-02-10, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdd48993669, moduleTitle=移动医疗医生端构建商业模式中的几个大坑（中）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdd48993669)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771743, encodeId=32f91e7174396, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=李克强：支持商业保险机构为个人和家庭提供个性化、差异化养老保障, objectType=article, longId=103018, objectId=488e10301892, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=488e10301892, replyNumber=0, likeNumber=95, createdTime=2017-08-10, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=488e10301892, moduleTitle=李克强：支持商业保险机构为个人和家庭提供个性化、差异化养老保障, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=488e10301892)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771738, encodeId=91e11e7173813, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=构建区域新型商业集团公司, objectType=article, longId=99172, objectId=a3bd991e2f1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a3bd991e2f1, replyNumber=0, likeNumber=57, createdTime=2017-12-28, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a3bd991e2f1, moduleTitle=构建区域新型商业集团公司, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a3bd991e2f1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771742, encodeId=23fc1e71742a1, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=未来制药企业之间的竞争是商业模式竞争, objectType=article, longId=102224, objectId=a22b102224b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a22b102224b5, replyNumber=0, likeNumber=83, createdTime=2018-04-26, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a22b102224b5, moduleTitle=未来制药企业之间的竞争是商业模式竞争, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a22b102224b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771719, encodeId=cc6c1e7171995, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=打击挂靠过票力度空前，医药商业如何转型？, objectType=article, longId=89885, objectId=bd3f8988577, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bd3f8988577, replyNumber=0, likeNumber=65, createdTime=2017-12-01, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bd3f8988577, moduleTitle=打击挂靠过票力度空前，医药商业如何转型？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bd3f8988577)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771739, encodeId=f8f51e7173952, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=山东：医保余额将可购买个人商业健康保险, objectType=article, longId=99380, objectId=c4f9993807d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4f9993807d, replyNumber=0, likeNumber=54, createdTime=2017-10-09, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4f9993807d, moduleTitle=山东：医保余额将可购买个人商业健康保险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c4f9993807d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771730, encodeId=a9111e7173030, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=美国三大医药商业企业的启示, objectType=article, longId=96990, objectId=7e4296990bf, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7e4296990bf, replyNumber=0, likeNumber=69, createdTime=2017-12-12, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7e4296990bf, moduleTitle=美国三大医药商业企业的启示, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7e4296990bf)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771721, encodeId=3f001e71721bc, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=这五款App，如何探索抗击心理疾病的商业闭环？, objectType=article, longId=90140, objectId=783390140b3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=783390140b3, replyNumber=0, likeNumber=62, createdTime=2017-11-30, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=783390140b3, moduleTitle=这五款App，如何探索抗击心理疾病的商业闭环？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=783390140b3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771732, encodeId=83961e71732f6, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=医药商业企业四大转型方向（下篇）, objectType=article, longId=97345, objectId=f6a39e34572, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f6a39e34572, replyNumber=0, likeNumber=60, createdTime=2017-10-25, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f6a39e34572, moduleTitle=医药商业企业四大转型方向（下篇）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f6a39e34572)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771729, encodeId=96a31e7172924, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=纯销商业生存和发展的前景几何？, objectType=article, longId=96695, objectId=34439669547, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34439669547, replyNumber=0, likeNumber=70, createdTime=2017-10-13, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34439669547, moduleTitle=纯销商业生存和发展的前景几何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34439669547)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771718, encodeId=497b1e7171873, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=移动医疗医生端构建商业模式中的几个大坑（上）, objectType=article, longId=89847, objectId=7d7d8984e6f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7d7d8984e6f, replyNumber=0, likeNumber=70, createdTime=2017-10-22, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7d7d8984e6f, moduleTitle=移动医疗医生端构建商业模式中的几个大坑（上）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7d7d8984e6f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771714, encodeId=fbdc1e71714de, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=药品零售并购潮起，新商业模式有待成型, objectType=article, longId=78312, objectId=c1b0e83123e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c1b0e83123e, replyNumber=0, likeNumber=62, createdTime=2016-12-06, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c1b0e83123e, moduleTitle=药品零售并购潮起，新商业模式有待成型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c1b0e83123e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771722, encodeId=83501e7172269, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=商业重构：医药市场巨大的投资机会, objectType=article, longId=91028, objectId=3a2f910283d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a2f910283d, replyNumber=0, likeNumber=66, createdTime=2018-02-10, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a2f910283d, moduleTitle=商业重构：医药市场巨大的投资机会, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3a2f910283d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771715, encodeId=30391e7171525, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=移动医疗三座大山：钱、政策、商业模式, objectType=article, longId=80373, objectId=4b60803e37b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4b60803e37b, replyNumber=0, likeNumber=64, createdTime=2016-10-19, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4b60803e37b, moduleTitle=移动医疗三座大山：钱、政策、商业模式, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4b60803e37b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771716, encodeId=437a1e71716db, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=酸奶补充益生菌只是商业骗局？, objectType=article, longId=80779, objectId=a29080e79ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a29080e79ab, replyNumber=0, likeNumber=77, createdTime=2016-12-06, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a29080e79ab, moduleTitle=酸奶补充益生菌只是商业骗局？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a29080e79ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771712, encodeId=efce1e7171272, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=NEJM：低廉的消毒蚊帐vs高昂的商业补片，疝修补术中应如何选择？, objectType=article, longId=63007, objectId=93086300e5a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=93086300e5a, replyNumber=0, likeNumber=64, createdTime=2016-03-19, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=93086300e5a, moduleTitle=NEJM：低廉的消毒蚊帐vs高昂的商业补片，疝修补术中应如何选择？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=93086300e5a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771713, encodeId=48c91e7171302, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=康哲药业斥资5亿美元获得阿斯利康两款心血管药物商业化权利, objectType=article, longId=64037, objectId=5e746403ed5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e746403ed5, replyNumber=0, likeNumber=68, createdTime=2016-06-27, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e746403ed5, moduleTitle=康哲药业斥资5亿美元获得阿斯利康两款心血管药物商业化权利, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5e746403ed5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771710, encodeId=b5ed1e717108c, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=Nature：抗衰老药黄芪提取物TA-65被控商业欺诈, objectType=article, longId=39589, objectId=5649395898c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5649395898c, replyNumber=0, likeNumber=86, createdTime=2015-07-17, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5649395898c, moduleTitle=Nature：抗衰老药黄芪提取物TA-65被控商业欺诈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5649395898c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1771709, encodeId=de071e717098d, content=<a href='/topic/show?id=62754005931' target=_blank style='color:#2F92EE;'>#商业#</a>, objectTitle=全球癌症药市场逼近千亿美元研发趋于商业化, objectType=article, longId=37738, objectId=e0413e7385e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e0413e7385e, replyNumber=0, likeNumber=68, createdTime=2015-02-02, rootId=0, userName=zhangxingru, userId=fd6238344589, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e0413e7385e, moduleTitle=全球癌症药市场逼近千亿美元研发趋于商业化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e0413e7385e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

商业

2020-05-29

zhangxingru (审核中...)

前往app查看评论内容

#商业#

两票制下，制药企业和商业企业怎么合作？

2017-12-02

zhangxingru (审核中...)

前往app查看评论内容

#商业#

移动医疗医生端构建商业模式中的几个大坑（中）

2018-02-10

zhangxingru (审核中...)

前往app查看评论内容

#商业#

李克强：支持商业保险机构为个人和家庭提供个性化、差异化养老保障

2017-08-10

zhangxingru (审核中...)

前往app查看评论内容

#商业#

构建区域新型商业集团公司

2017-12-28

zhangxingru (审核中...)

前往app查看评论内容

#商业#

未来制药企业之间的竞争是商业模式竞争

2018-04-26

zhangxingru (审核中...)

前往app查看评论内容

#商业#

打击挂靠过票力度空前，医药商业如何转型？

2017-12-01

zhangxingru (审核中...)

前往app查看评论内容

#商业#

山东：医保余额将可购买个人商业健康保险

2017-10-09

zhangxingru (审核中...)

前往app查看评论内容

#商业#

美国三大医药商业企业的启示

2017-12-12

zhangxingru (审核中...)

前往app查看评论内容

#商业#

这五款App，如何探索抗击心理疾病的商业闭环？

2017-11-30

zhangxingru (审核中...)

前往app查看评论内容

#商业#

医药商业企业四大转型方向（下篇）

2017-10-25

zhangxingru (审核中...)

前往app查看评论内容

#商业#

纯销商业生存和发展的前景几何？

2017-10-13

zhangxingru (审核中...)

前往app查看评论内容

#商业#

移动医疗医生端构建商业模式中的几个大坑（上）

2017-10-22

zhangxingru (审核中...)

前往app查看评论内容

#商业#

药品零售并购潮起，新商业模式有待成型

2016-12-06

zhangxingru (审核中...)

前往app查看评论内容

#商业#

商业重构：医药市场巨大的投资机会

2018-02-10

zhangxingru (审核中...)

前往app查看评论内容

#商业#

移动医疗三座大山：钱、政策、商业模式

2016-10-19

zhangxingru (审核中...)

前往app查看评论内容

#商业#

酸奶补充益生菌只是商业骗局？

2016-12-06

zhangxingru (审核中...)

前往app查看评论内容

#商业#

NEJM：低廉的消毒蚊帐vs高昂的商业补片，疝修补术中应如何选择？

2016-03-19

zhangxingru (审核中...)

前往app查看评论内容

#商业#

康哲药业斥资5亿美元获得阿斯利康两款心血管药物商业化权利

2016-06-27

zhangxingru (审核中...)

前往app查看评论内容

#商业#

Nature：抗衰老药黄芪提取物TA-65被控商业欺诈

2015-07-17

zhangxingru (审核中...)

前往app查看评论内容

#商业#

全球癌症药市场逼近千亿美元研发趋于商业化

2015-02-02

科室
- - 订阅+
  - 更多科室
工具
服务